Century Therapeutics (IPSC) Operating Margin (2022 - 2025)
Century Therapeutics (IPSC) reported Operating Margin of 67.95% for Q1 2025, up 372982.0% year-over-year from N/an in Q1 2024, and down 96.2% quarter-over-quarter from 1789.96% in Q4 2024.
Century Therapeutics (IPSC) Operating Margin (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has 4 years of Operating Margin data on file, last reported at 67.95% in Q1 2025.
- Operating Margin for Q1 2025 came in at 67.95%, up 372982.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1.85% (up 39508.0% YoY), and the FY2025 annual result was 1.86%, up 39514.0% from the prior year.
- Operating Margin slipped to 67.95% in Q1 2025 per IPSC's latest filing, from 1789.96% in the prior quarter.
- Over five years, Operating Margin peaked at 1789.96% in Q4 2024 and troughed at 35431.31% in Q2 2023.
- A 4-year average of 7847.0% and a median of 3661.87% in 2024 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2023 and 2024: Operating Margin sank 3318554 bps in 2023, then soared 3092353 bps in 2024.
- A 4-year view of Operating Margin shows it stood at 6392.71% in 2022, then sank by 155 bps to 16329.1% in 2023, then soared by 111 bps to 1789.96% in 2024, then tumbled by 96 bps to 67.95% in 2025.
- Business Quant data shows IPSC's Operating Margin at 67.95% in Q1 2025, 1789.96% in Q4 2024, and 4398.1% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 67.95% |
| Dec 31, 2024 | 1,789.96% |
| Sep 30, 2024 | -4,398.10% |
| Jun 30, 2024 | -4,507.78% |
| Mar 31, 2024 | -3,661.87% |
| Dec 31, 2023 | -16,329.10% |
| Sep 30, 2023 | -24,071.62% |
| Jun 30, 2023 | -35,431.31% |
| Mar 31, 2023 | -1,865.17% |
| Dec 31, 2022 | -6,392.71% |
| Sep 30, 2022 | -1,427.07% |
| Jun 30, 2022 | -2,245.77% |
| Mar 31, 2022 | -3,538.37% |